Evidence map›Paper›PMID 21502812›Full record

ArticleCell cycle (Georgetown, Tex.)2011

Antagonistic crosstalk between APC and HIF-1α.

Inke Näthke, Sonia Rocha

Open access · hybridAbstract read
In one paragraph

Article in Cell cycle (Georgetown, Tex.), 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
0.2field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 18 citations in OpenAlex.

  1. Multi-omics exploration of hypoxia in gastric cancer.World journal of surgical oncology · 2026
    Article
  2. Review
  3. Review
  4. Article
  5. Article
  6. Review
  7. Review
  8. Review
  9. The role of hypoxia in inflammatory disease (review).International journal of molecular medicine · 2015
    Review
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Inke NäthkeUniversity of Dundee, Dundee, Scotland, UK.
Sonia Rocha
University of Dundee · GB

Funding

Cancer Research UK 11243Cancer Research UK A11243Wellcome Trust 083524
6 · The paper itself

Abstract

Most colorectal cancers have mutations in the tumor suppressor APC. The best-understood function of APC is its participation in a protein complex that regulates the availability of β-catenin. Solid tumors are characterized by the presence of hypoxia as well as inflammation, which leads to the upregulation of Hypoxia Inducible Factors like HIF-1α. We recently demonstrated a novel antagonistic link between APC and HIF-1α. We found that hypoxia results in reduced levels of APC mRNA and protein via a direct HIF-1α-dependent mechanism. Similarly, APC mediates the repression of HIF-1α. However, this requires wild-type APC, low levels of β-catenin and NFκB activity. These results reveal the downregulation of APC as a novel mechanism that contributes to the survival advantage induced by hypoxia and cytokines such as TNFα. Our data indicate that loss-of-function mutations in APC result in the engagement of the hypoxia response. Importantly, this suggests that other stimuli that induce HIF, such as inflammatory cytokines and oncogenes, alter APC function.

Indexed as

Adenomatous Polyposis Coli Proteinbeta CateninCell HypoxiaDown-RegulationHumansHypoxia-Inducible Factor 1, alpha SubunitMutationNF-kappa BSignal TransductionTumor Cells, CulturedTumor Necrosis Factor-alphaWnt ProteinsAdenomatous Polyposis Coli ProteinAPC protein, humanbeta CateninHypoxia-Inducible Factor 1, alpha SubunitNF-kappa BTumor Necrosis Factor-alphaWnt Proteins

Identifiers

PMID21502812
PMCPMC3127156
OpenAlexW2131787067

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.